Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Sarcoma 1

Conditions

Sarcoma 172 Glioblastoma 72 Gliosarcoma 70 Brain Neoplasms 41 Osteosarcoma 40 Neoplasms 40 Astrocytoma 38 Recurrence 35 Melanoma 33 Oligodendroglioma 32 Gastrointestinal Stromal Tumors 31 Breast Neoplasms 31 Glioma 30 Lymphoma 29 Dendritic Cell Sarcoma, Interdigitating 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Neoplasm Metastasis 28 Central Nervous System Neoplasms 27 Burkitt Lymphoma 26 Bone Neoplasms 26 Ovarian Neoplasms 25 Colorectal Neoplasms 24 Neuroblastoma 22 Lymphoma, Non-Hodgkin 22 Lymphoma, Large B-Cell, Diffuse 22 Stomach Neoplasms 21 Sarcoma, Ewing 21 Lung Neoplasms 19 Leukemia, Myeloid, Acute 19 Leukemia 19

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hemorrhage × Sarcoma × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡